CD17 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD17 monoclonal antibodies for research applications. CD17 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD17, also known as the T-cell surface glycoprotein, plays a crucial role in immune response regulation and T-cell activation. Its expression is significant in both normal and pathological conditions, making CD17 an important target for understanding immune system dynamics and potential therapeutic interventions. CD17 monoclonal antibodies enable precise detection and analysis of CD17 expression patterns across various cell types and tissues. Researchers can utilize CD17 monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms involved in immune responses. CD17 monoclonal antibodies support detailed examination of T-cell development, activation, and function in health and disease states. Santa Cruz Biotechnology monoclonal antibodies for CD17 research continue to advance our understanding of immunology and support breakthrough discoveries in the scientific community.